Shares Drop
Shares Drop
The announcements prompted a 9 % decline in Adaptive’s shares in pre‑market trading. Despite the split and financing, the company stresses that no assurance exists that the separation will result in a transaction or any specific outcome. The convertible notes’ terms remain to be finalized at pricing, but the structure aims to limit potential equity dilution while providing capital to accelerate MRD initiatives.
17/06/2026 | Adaptive Biotechnologies Corporation